Related references
Note: Only part of the references are listed.Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens
A. B. Versluys et al.
BONE MARROW TRANSPLANTATION (2021)
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
Christina Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial
Martin G. Sauer et al.
LEUKEMIA (2020)
Prospective Open-Label Phase II Trial of Individualized Anti-Thymocyte Globulin for Improved T-Cell Reconstitution after Pediatric Allogeneic Hematopoietic Cell Transplantation: The Parachute-Study
Rick Admiraal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Expanded Comorbidity Definitions Improve Applicability of the Hematopoietic Stem Cell Transplantation-Comorbidity Index for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Stem Cell Transplantation
Brian D. Friend et al.
BLOOD (2020)
The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010)
Fernand Freycon et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2019)
Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study
Adriana Balduzzi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01
Barbara De Moerloose et al.
PEDIATRIC BLOOD & CANCER (2019)
Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
J. B. Langenhorst et al.
BLOOD ADVANCES (2019)
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
Peter Bader et al.
BLOOD ADVANCES (2019)
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation
S. Corbacioglu et al.
BONE MARROW TRANSPLANTATION (2018)
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Sarah A. Buckley et al.
HAEMATOLOGICA (2017)
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Sarah A. Buckley et al.
HAEMATOLOGICA (2017)
Long-Term Outcomes after Treatment with Clofarabine Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome
Gheath Alatrash et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation
Rick Admiraal et al.
BLOOD (2016)
Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group
Rob Pieters et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?
Daisuke Araki et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab
Laura Willemsen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis
Rick Admiraal et al.
LANCET HAEMATOLOGY (2015)
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study
F. Locatelli et al.
BONE MARROW TRANSPLANTATION (2015)
Fludarabine and Exposure-Targeted Busulfan Compares Favorably with Busulfan/Cyclophosphamide-Based Regimens in Pediatric Hematopoietic Cell Transplantation: Maintaining Efficacy with Less Toxicity
I. H. Bartelink et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
Gertjan J. L. Kaspers et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Outcomes of Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adults Compared with Children and Older Adults with Acute Myeloid Leukemia
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
Francesco Buccisano et al.
BLOOD (2012)
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
Wing Leung et al.
BLOOD (2012)
Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients Towards Individualized Dosing
Imke H. Bartelink et al.
CLINICAL PHARMACOKINETICS (2012)
The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling
Benigno C. Valdez et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS
Borje S. Andersson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Long-term outcome after static intensity-modulated total body radiotherapy using compensators stratified by pediatric and adult cohorts
Ralf A. Schneider et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia:: A Pediatric Blood and Marrow Transplant Consortium study
N Bunin et al.
BONE MARROW TRANSPLANTATION (2003)
Share Paper
